{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:21:11Z","timestamp":1784208071525,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":5151,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1111\/j.1538-7836.2008.03133.x","type":"journal-article","created":{"date-parts":[[2008,8,22]],"date-time":"2008-08-22T08:53:16Z","timestamp":1219395196000},"page":"1933-1943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2"],"prefix":"10.1016","volume":"6","author":[{"given":"P.C.J.","family":"ARMSTRONG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J.","family":"TRUSS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.Y.","family":"ALI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"DHANJI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"VOJNOVIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.N.M.","family":"ZAIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"BISHOP-BAILEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"PAUL-CLARK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.T.","family":"TUCKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"MITCHELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.D.","family":"WARNER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0010","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0015","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/01.CIR.0000142056.69970.DB","article-title":"Terms and conditions: semantic complexity and aspirin resistance","volume":"110","author":"Hennekens","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0020","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","article-title":"Aspirin resistance: position paper of the Working Group on Aspirin Resistance","volume":"3","author":"Michelson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0025","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00392-006-0424-5","article-title":"Aspirin resistance \u2013 does it clinically matter?","volume":"95","author":"Schror","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ncpcardio0728","article-title":"Drug insight: aspirin resistance \u2013 fact or fashion?","volume":"4","author":"Patrono","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0040","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","article-title":"Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study","volume":"115","author":"Gurbel","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd1929","article-title":"COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs","volume":"5","author":"Mitchell","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0060","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2005.06.058","article-title":"Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease","volume":"46","author":"Maree","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0065","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V69.1.180.180","article-title":"Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs","volume":"69","author":"Reilly","year":"1987","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0022-3565(25)22402-8","article-title":"Characterization of human peripheral blood monocyte thromboxane A2 receptors","volume":"270","author":"Allan","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0075","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1160\/TH05-10-0653","article-title":"Dose- and time-dependent antiplatelet effects of aspirin","volume":"95","author":"Perneby","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.thromres.2006.11.012","article-title":"Measuring antiplatelet drug effects in the laboratory","volume":"120","author":"Harrison","year":"2007","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0085","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.90.24.11693","article-title":"Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase","volume":"90","author":"Mitchell","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0090","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0095","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1096\/fj.06-6615com","article-title":"Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events","volume":"20","author":"Mitchell","year":"2006","journal-title":"FASEB J"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0049-3848(95)93881-Y","article-title":"Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of platelet agonists and antagonists","volume":"77","author":"Bednar","year":"1995","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/09537100120071040","article-title":"Monitoring the effects of platelet glycoprotein IIb\/IIIa antagonists with a microtiter plate method for detection of platelet aggregation","volume":"12","author":"Krause","year":"2001","journal-title":"Platelets"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/09537100020032846","article-title":"The balance of concurrent aggregation and deaggregation processes in platelets is linked to differential occupancy of ADP receptor subtypes","volume":"12","author":"Maayani","year":"2001","journal-title":"Platelets"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ab.2006.06.037","article-title":"Monitoring modulators of platelet aggregation in a microtiter plate assay","volume":"357","author":"Moran","year":"2006","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0120","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0125","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1006\/abio.1994.1066","article-title":"A colorimetric method for the measurement of platelet adhesion in microtiter plates","volume":"216","author":"Bellavite","year":"1994","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0130","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780250509","article-title":"Aspirin survival in human blood modulated by the concentration of erythrocytes","volume":"25","author":"Costello","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0090-6980(73)90121-4","article-title":"Arachidonic acid-induced human platelet aggregation and prostaglandin formation","volume":"4","author":"Silver","year":"1973","journal-title":"Prostaglandins"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0140","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0090-6980(79)80050-7","article-title":"Arachidonic acid causes lysis of human platelets in an artificial medium: protection by plasma","volume":"17","author":"Ts\u2019ao","year":"1979","journal-title":"Prostaglandins"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0145","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1182\/blood-2002-05-1363","article-title":"The roles of alpha IIbbeta 3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation","volume":"101","author":"Cho","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0150","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1160\/TH06-05-0242","article-title":"Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood","volume":"96","author":"Toth","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0038-1650143","article-title":"Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets","volume":"45","author":"Di Minno","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0049-3848(86)90299-9","article-title":"Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients","volume":"42","author":"Riess","year":"1986","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0165","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1038\/sj.bjp.0706401","article-title":"Antiplatelet drugs","volume":"147","author":"Born","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0170","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1124\/mol.51.6.907","article-title":"Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid","volume":"51","author":"Mitchell","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bjp.0701076","article-title":"Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor","volume":"121","author":"Riendeau","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0180","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3390607","article-title":"Kinetic basis for selective inhibition of cyclo-oxygenases","volume":"3","author":"Gierse","year":"1999","journal-title":"Biochem J"},{"key":"10.1111\/j.1538-7836.2008.03133.x_bb0185","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.ATV.0000145980.39477.a9","article-title":"Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance","volume":"24","author":"Cattaneo","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2008.03133.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622127418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622127418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2008.03133.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:43:38Z","timestamp":1761533018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622127418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1538783622127418"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03133.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1127184.584341","asserted-by":"object"}]},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03133.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}